Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Interview of the week

How Straumann is shaping the dental landscape across different markets

HBI recently hosted an oral health webinar with speakers Dr. Neil Sikka, Chief Dental Officer at Bupa Insurance, and Sara Dalmasso, Head of Enterprise Solutions at Straumann Group. The session explored the role of AI in dentistry and how to integrate it effectively, the link between oral health and general health, sustainability, and balancing clinical judgement with the use of technology. Post webinar, here HBI speaks to Dalmasso for a deeper dive on certain points (and new ones), to better understand how Straumann Group is shaping up the dental landscape and what its market learnings are.  

How new primary care venture Lilliancare can address Germany’s GP shortage — an interview with Daniel Hefel

Daniel Hefel has spent two decades working in Germany’s private healthcare sector. Recently he decided to try his hand at entrepreneurship. In an interview with HBI, he explained the business model behind his new primary care venture, LillianCare, and how it can help solve Germany’s doctor shortage.

Wellster’s medicinal weight loss model and GLP-1s in Germany

HBI spoke with Dr. Manuel Nothelfer, founder at Wellster Healthtech Group based in Germany, part of a digital ecosystem that integrates a range of medical brands including online medicinal weight loss service GoLighter. Ahead of him taking part in a panel session on prescription weight loss at the HBI conference in Paris in March, he gives us an insight into the GLP-1 market in Germany, Wellster’s GoLighter model (which includes nutritional advice), and business learnings from the Group, having achieved profitability in October.  

Which healthtech sectors are mature enough to be of interest to private equity?

The year ahead will undoubtedly bring a plethora of new opportunities for PE. And one area we’re seeing exciting new activity in is healthtech. We spoke with Thomas Hagemeijer, once of global management consulting firm AT Kearney, and then digital consultancy TLGG as healthcare lead, about the Private Equity in healthcare landscape, which sectors are reaching maturity, and the challenges of driving healthcare innovation without risking care quality.

How Numan delivers its online healthcare services for weight loss drugs

HBI spoke with Bryony Henderson, Medical Director at Numan, and its CEO and Founder Sokratis Papafloratos, about the GLP-1 market in the UK, and on how the digital healthcare provider is scaling its online-only service model.

Exploring the GCC’s prospective $11 billion GLP-1 RA market — ‘a unique opportunity to lead in this space’

Demand for GLP-1 receptor agonists (the class of drugs used to treat obesity and diabetes) has been growing rapidly, opening up more and more opportunities in the market, such as ‘holistic’ online prescription services. We’ve seen both the positives and negatives of the use of GLP-1 RAs in the US and Europe, from transforming people’s health for the better to misuse and inappropriate supply. But what do we know about the market in the Middle East?

Interview: Stéphane Carré, Amethyst Radiotherapy Group

In this interview Stéphane Carré, CEO of pan-European radiotherapy provider Amethyst Radiotherapy, explains how his company is aiming to increase access to state of the art radiotherapy services, and provide a holistic care journey geared towards making the patient feel as comfortable as possible. Stéphane Carré will be sharing more about his business model at HBI 2025, in Paris, March 24-26, 2025.

How AI can revolutionise healthcare and stand out while doing it – Frederik Brabant, Chief Strategy and Medical Officer of Corti

AI solutions for healthcare are evolving at pace, and fast-growth Danish startup Corti is no exception. After closing a $60 million Series B funding round last year, the software company says it is now attracting interest from Silicon Valley figures and major tech companies. But what makes it stand out from its competitors? We spoke with Corti’s Chief Strategy and Medical Officer, Frederik Brabant, about how exactly the product is built and works, why it’s making waves, and what its future looks like. 

Why pharma services is such an attractive investment space

Last week Telemos Capital, a European mid-market private equity firm backed by family capital, bought Helios Global Group, a full-service global healthcare communications provider, from NorthEdge, a regional lower mid-market private equity company. We spoke with one of the deal's advisors — Tom Cowap, Managing Director at Baird, an employee-owned international investment bank — about how this is a bellwether for growing private equity interest in the med comms and wider pharma services space.

Healthcare providers and researchers can use software to get the most out of health records — an interview with Dexter

Dexter is a UK-based software company that provides a platform designed to get the most out of electronic healthcare records. The platform can be used to automate the process of running clinical trials based on ‘real world’ evidence from health record data, but it can also be used by healthcare providers to improve their operations (this part of the platform is called DexterCare). 

Our Services

Company

Resources

Log in
Register
Log in
Register

Our Services

Company

Resources

Find Us